• Back to p53 (Tumor suppressor p53, TP53, Li-Fraumeni syndrome)

• Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 1998 Oct 9;282 (5387):290-3
• Engel P, Francis D, Graem N. Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas. Association with p53 expression and review of the literature. APMIS. 1998 Apr;106 (4):449-55
• Hansen R, Oren M. p53; from inductive signal to cellular effect. Curr Opin Genet Dev. 1997 Feb;7 (1):46-51
• Harris CC. p53: at the crossroads of molecular carcinogenesis and molecular epidemiology. J Investig Dermatol Symp Proc. 1996 Apr;1 (2):115-8
• Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991 Jul 5;253 (5015):49-53
• Hung J, Anderson R. p53: functions, mutations and sarcomas. Acta Orthop Scand Suppl. 1997 Feb;273:68-73
• Jensen V, Jensen ML, Kiaer H, Andersen J, Melsen F. MIB-1 expression in breast carcinomas with medullary features. An immunohistological study including correlations with p53 and bcl-2. Virchows Arch. 1997 Aug;431 (2):125-30
• Khan S, Do KA, Kuhnert P, Pillay SP, Papadimos D, Conrad R, Jass JR. Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: an endoscopic study. Pathology. 1998 May;30 (2):136-40
• Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol. 1998 Sep;16 (9):3158-68
• Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997 Feb 7;88 (3):323-31
• Milczarek GJ, Martinez J, Bowden GT. p53 Phosphorylation: biochemical and functional consequences. Life Sci. 1997;60 (1):1-11
• Milner J. Structures and functions of the tumor suppressor p53. Pathol Biol (Paris). 1997 Dec;45 (10):797-803
• Mulder JW, Wielenga VJ, Pals ST, Offerhaus GJ. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis. Histochem J. 1997 Jun;29 (6):439-52
• Prokocimer M, Unger R, Rennert HS, Rotter V, Rennert G. Pooled analysis of p53 mutations in hematological malignancies. Hum Mutat. 1998;12 (1):4-18
• Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C, Schartl M. p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem. 2000 Dec 1;275 (48):37469-73
• Shaw PH. The role of p53 in cell cycle regulation. Pathol Res Pract. 1996 Jul;192 (7):669-75
• Soddu S, Sacchi A. p53: prospects for cancer gene therapy. Cytokines Cell Mol Ther. 1998 Sep;4 (3):177-85
• Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg. 1998 Nov;85 (11):1460-7
• Tominaga O, Hamelin R, Remvikos Y, Salmon RJ, Thomas G. p53 from basic research to clinical applications. Crit Rev Oncog. 1992;3 (3):257-82
• Weller M. Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res. 1998 Jun;292 (3):435-45
• Wynford-Thomas D, Blaydes J. The influence of cell context on the selection pressure for p53 mutation in human cancer. Carcinogenesis. 1998 Jan;19 (1):29-36